Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 13,851 | 13,843 | 13,959 | 12,210 | 11,916 |
| Cost of Goods | 1,959 | 1,962 | 2,251 | 1,615 | 1,590 |
| Gross Profit | 11,892 | 11,881 | 11,708 | 10,595 | 10,326 |
| Operating Expenses | 7,974 | 8,205 | 7,166 | 7,521 | 7,694 |
| Operating Income | 4,877 | 4,638 | 4,793 | 3,689 | 3,222 |
| Other Income | 1,248 | 178 | 139 | -499 | 146 |
| Pre-tax Income | 6,125 | 4,816 | 4,932 | 3,190 | 3,368 |
| Income Tax | 1,877 | 1,962 | 1,758 | 1,244 | 1,213 |
| Net Income Continuous | 4,248 | 2,854 | 3,174 | 1,946 | 2,155 |
| Net Income Discontinuous | N/A | -114 | -112 | -223 | 551 |
| Net Income | $4,248 | $2,740 | $3,062 | $1,723 | $2,706 |
| EPS Basic Total Ops | 0.29 | 0.17 | 0.17 | 0.10 | 0.15 |
| EPS Basic Continuous Ops | 0.29 | 0.17 | 0.18 | 0.11 | 0.12 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | 0.03 |
| EPS Diluted Total Ops | 0.29 | 0.17 | 0.17 | 0.10 | 0.15 |
| EPS Diluted Continuous Ops | 0.29 | 0.17 | 0.18 | 0.11 | 0.12 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | 0.03 |
| EBITDA(a) | $5,599 | $5,353 | $5,527 | $4,431 | $3,991 |